Insiders / Balcom Alexandra

Balcom Alexandra

CIK 1862147personinsider
Companies
2
First seen
Jan 7, 2026
Last activity
Jun 3, 2026

Companies

CompanyRoleShares heldPeak heldTradesLatest
Nuvalent, Inc. · NUVLExecutive85,533150,22615
Crescent Biopharma, Inc. · CBIODirector11,0501

All securities held

3 positions · latest reported per filing
CompanySecuritySharesAs of
Crescent Biopharma, Inc.Stock Option (Right to Buy)Derivative11,050Jun 2, 2026
Nuvalent, Inc.Class A Common Stock85,533Mar 25, 2026
Nuvalent, Inc.Stock Option (Right to Buy)Derivative150,226Mar 24, 2026

Activity

InsidersInstitutions
This person's insider trades (Form 4), across every company.
DateActionCompanyValueShares ΔPosition afterImpact
Mar 25, 2026SellNUVL
Nuvalent, Inc.
Class A Common Stock
$1.37M-14K
-13.81%
85,533
0.11% of shares
medium
Mar 24, 2026SellNUVL
Nuvalent, Inc.
Class A Common Stock
$735.5K-8K
-7.10%
100,393
0.13% of shares
medium
Mar 24, 2026SellNUVL
Nuvalent, Inc.
Class A Common Stock
$247.0K-3K
-2.35%
108,064
0.14% of shares
medium
Jan 5, 2026SellNUVL
Nuvalent, Inc.
Class A Common Stock
$189.0K-2K
-2.21%
85,231
0.11% of shares
medium
Jan 6, 2026SellNUVL
Nuvalent, Inc.
Class A Common Stock
$159.1K-2K
-1.96%
81,958
0.10% of shares
medium
Jan 6, 2026SellNUVL
Nuvalent, Inc.
Class A Common Stock
$127.8K-1K
-1.56%
83,593
0.11% of shares
medium
Mar 24, 2026SellNUVL
Nuvalent, Inc.
Class A Common Stock
$111.9K-1K
-1.16%
99,233
0.13% of shares
medium
Jan 5, 2026SellNUVL
Nuvalent, Inc.
Class A Common Stock
$108.4K-1K
-1.27%
87,160
0.11% of shares
medium
Jan 5, 2026SellNUVL
Nuvalent, Inc.
Class A Common Stock
$83.7K-871
-0.98%
88,279
0.11% of shares
low
Jan 5, 2026SellNUVL
Nuvalent, Inc.
Class A Common Stock
$31.2K-317
-0.37%
84,914
0.11% of shares
low